ARS Pharmaceuticals
SPRY
SPRY
115 hedge funds and large institutions have $533M invested in ARS Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 46 increasing their positions, 24 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+2
Holders Change %
+1.77%
% of All Funds
1.67%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
24
Increased
46
Reduced
24
Closed
21
Calls
$19.2M
Puts
$821K
Net Calls
+$18.4M
Net Calls Change
+$13M
Top Buyers
| 1 |
1
BlackRock
New York
|
$34.8M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$27.7M |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$10.2M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$15.8M |
| 5 |
KPF
5
K2 Principal Fund
Toronto,
Ontario, Canada
|
$20.9M |
